Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine or Haloperidol in First Episode Schizophrenia
NCT00169091Phase 4Terminated
- Sponsor
- Harvard Medical School
- Start
- Mar 1996
- Primary completion
- Sep 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clozapine in schizophrenia (2 arms), sponsored by Harvard Medical School. Primary endpoint: Brief Psychiatric Rating Scale. Started Mar 1996; status: terminated.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00169091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00169091.